POSSIBILITIES OF FORECASTING EARLY PREECLAMPSIA IN 11-13 WEEK OF GESTATION
The purpose of the study was to study the levels of placental growth factor (PlGF) and soluble receptor-1 vascular endothelial growth factor (sVEGF-R1) in the mother’s serum during normal pregnancy and pre-eclampsia developed before 34 weeks of pregnancy in the period 11–13 weeks. Material and metho...
Saved in:
| Main Authors: | L. D. Belotserkovtseva, L. V. Kovalenko, D. P. Telitsyn |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Siberian Branch Publishing House
2019-05-01
|
| Series: | Сибирский научный медицинский журнал |
| Subjects: | |
| Online Access: | https://sibmed.elpub.ru/jour/article/view/137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients
by: Ying Jiang, et al.
Published: (2023-09-01) -
Infectious lesions of placenta as cause of miscarriage
by: A. V. Kolobov, et al.
Published: (2015-04-01) -
Multiple intraplacental hematomas preceding clinical deterioration in preeclampsia with severe features: A case report
by: Nicholas A. Orlando, MSc, et al.
Published: (2025-09-01) -
Predictive value of maternal serum placental growth factor, maternal clinical features, and fetal ultrasound indicators in preeclampsia
by: Yuee Ling, et al.
Published: (2025-04-01) -
Antithyroglobulin and Antiperoxidase Antibodies Can Negatively Influence Pregnancy Outcomes by Disturbing the Placentation Process and Triggering an Imbalance in Placental Angiogenic Factors
by: Kamila Tańska, et al.
Published: (2024-11-01)